Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $5.44 -0.18 (-3.22%) Closing price 07/11/2025 03:54 PM EasternExtended Trading$5.44 +0.00 (+0.02%) As of 07/11/2025 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 93.56%, with a year-to-date return of 71.58%. In the past month, the stock has increased 40.18%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $5.44 with a market cap of $195.59 million and volume of 5,792 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.81%1 Month Performance+40.18%3 Month Performance+79.80%Year-To-Date Performance+71.58%1 Year Performance+93.56% EPRX Stock Chart for Saturday, July, 12, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$5.57$5.44-2.37%$5.54$5.365,792 shs$195.59 million07/10/2025$5.46$5.57+2.03%$5.68$5.493,595 shs$200.32 million07/09/2025$5.59$5.46-2.33%$5.66$5.4610,877 shs$196.34 million07/08/2025$5.54$5.59+0.92%$5.90$5.3910,733 shs$201.02 million07/07/2025$5.47$5.54+1.35%$5.67$5.396,820 shs$199.18 million07/04/2025$5.47$5.47$5.74$5.308,647 shs$196.52 million07/03/2025$5.47$5.47-0.09%$5.74$5.308,647 shs$196.51 million07/02/2025$5.84$5.47-6.34%$5.75$5.3912,256 shs$196.70 million07/01/2025$5.76$5.84+1.39%$6.20$5.8221,918 shs$210.01 million06/30/2025$5.30$5.76+8.68%$5.90$5.3028,210 shs$207.13 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$4.62$5.30+14.72%$5.43$4.6727,059 shs$190.59 million06/26/2025$4.31$4.62+7.19%$4.68$4.406,013 shs$166.14 million06/25/2025$4.35$4.31-0.92%$4.49$4.312,977 shs$154.99 million06/24/2025$4.38$4.35-0.68%$4.41$4.333,972 shs$156.43 million06/23/2025$4.32$4.38+1.39%$4.41$4.1915,007 shs$157.49 million06/20/2025$4.24$4.32+1.89%$4.49$4.2210,162 shs$155.35 million06/19/2025$4.24$4.24$4.33$4.224,922 shs$152.47 million06/18/2025$4.27$4.24-0.70%$4.33$4.224,922 shs$152.46 million06/17/2025$4.17$4.27+2.40%$4.36$4.1222,495 shs$153.54 million06/16/2025$3.86$4.17+8.03%$4.20$3.9410,162 shs$149.94 million06/13/2025$3.88$3.86-0.52%$3.95$3.854,408 shs$138.79 million06/12/2025$3.93$3.88-1.27%$3.96$3.8813,527 shs$139.09 million06/11/2025$3.98$3.93-1.26%$4.00$3.8816,784 shs$140.89 million Related Companies CorMedix Stock Chart Immunome Stock Chart Syndax Pharmaceuticals Stock Chart KalVista Pharmaceuticals Stock Chart Replimune Group Stock Chart Xeris Biopharma Stock Chart Vir Biotechnology Stock Chart Gyre Therapeutics Stock Chart Nuvation Bio Stock Chart Sana Biotechnology Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
